Bienville Capital Management LLC Sells 324,451 Shares of Omada Health, Inc. $OMDA

Bienville Capital Management LLC trimmed its position in shares of Omada Health, Inc. (NASDAQ:OMDA) by 36.1% during the 2nd quarter, Holdings Channel reports. The fund owned 573,314 shares of the company’s stock after selling 324,451 shares during the period. Omada Health makes up approximately 1.7% of Bienville Capital Management LLC’s investment portfolio, making the stock its 20th biggest position. Bienville Capital Management LLC’s holdings in Omada Health were worth $12,584,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Perceptive Advisors LLC purchased a new stake in Omada Health during the second quarter valued at $44,402,000. BlackRock Inc. purchased a new position in shares of Omada Health in the 2nd quarter worth $48,775,000. Millennium Management LLC increased its holdings in shares of Omada Health by 1,195.0% in the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after buying an additional 2,096,705 shares during the last quarter. Jefferies Financial Group Inc. bought a new stake in shares of Omada Health in the 4th quarter worth about $16,948,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Omada Health during the 1st quarter valued at about $10,401,000.

Omada Health Stock Down 3.1%

OMDA opened at $21.50 on Thursday. The stock’s fifty day moving average is $22.70 and its two-hundred day moving average is $17.84. The company has a market capitalization of $1.32 billion, a P/E ratio of 430.00 and a beta of 1.86. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. The business had revenue of $87.83 million for the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a return on equity of 2.60% and a net margin of 1.39%. Equities analysts anticipate that Omada Health, Inc. will post 0.09 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently commented on OMDA. Weiss Ratings upgraded Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research report on Tuesday, August 11th. BTIG Research raised their price objective on Omada Health from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Monday, August 10th. BMO Capital Markets reiterated an “outperform” rating and issued a $24.00 target price on shares of Omada Health in a report on Friday, August 7th. Canaccord Genuity Group boosted their target price on Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a research report on Tuesday, July 21st. Finally, JPMorgan Chase & Co. raised their price target on Omada Health from $26.00 to $30.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. Eleven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $26.50.

Insider Activity

In other Omada Health news, CEO Sean Duffy sold 25,886 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $22.68, for a total transaction of $587,094.48. Following the transaction, the chief executive officer owned 411,861 shares of the company’s stock, valued at approximately $9,341,007.48. This trade represents a 5.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Steven Cook sold 33,000 shares of the business’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $19.89, for a total transaction of $656,370.00. Following the completion of the sale, the chief financial officer owned 133,359 shares of the company’s stock, valued at approximately $2,652,510.51. This represents a 19.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 277,406 shares of company stock worth $5,907,726. 6.38% of the stock is owned by company insiders.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.